Filing Details

Accession Number:
0001654954-22-012673
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-19 16:16:25
Reporting Period:
2022-09-14
Accepted Time:
2022-09-19 16:16:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1101026 Zivo Bioscience Inc. ZIVO Biological Products, (No Disgnostic Substances) (2836) 870699977
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1436075 D. Christopher Maggiore 4788 Nobles Pond Dr. Nw
Canton OH 44718
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-14 5,200 $3.53 808,305 No 4 P Direct
Common Stock Acquisiton 2022-09-14 2,000 $3.55 810,305 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.45 to $3.7257 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.435 to $3.93 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.